Stanley Druckenmiller acquired 1.37 Million Insmed shares worth $132 Million. That's 3.82% of their equity portfolio (9th largest holding). The first Insmed trade was made in Q2 2020. Since then Stanley Druckenmiller bought shares three more times and sold shares on one occasions. The stake costed the investor $101 Million, netting the investor a gain of 30% so far.